Image

Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2

Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2

Recruiting
8-13 years
Male
Phase N/A

Powered by AI

Overview

Reduced hormone insulin-like 3, exclusively secreted by Leydig cells, has been identified as the recognized mechanism for cryptorchidism. Testicular macrophages residing in the testicular interstitium were thought to play a vital role in maintaining hormone secretion of Leydig cells. However, the contribution of macrophages to cryptorchidism remained poorly understood. Here, after 14 days of ketoconazole treatment, levels of both Trem2 and insulin-like 3 significantly decrease in human embryonic testes compared to the untreated control group. Conversely, 14 days of luteinizing hormone stimulation lead to elevated levels of Trem2 and insulin-like 3 in the testes compared to the untreated control group. Additionally, researchers find a positive correlation between Trem2 and insulin-like 3 expression in a human ex vivo tissue culture model. In summary, the study will propose Trem2 as a novel target for maintaining normal testicular descent by regulating the testicular immune microenvironment.

Eligibility

Inclusion Criteria:

-

  1. Termination of pregnancy is not related to the health of the fetus.

-

2. The fetus is intact in development and free of malformations and abnormalities.

-

       3. Estimation of gestational age based on parietal-rump length must be between 8
          and 13 weeks of gestation.

Exclusion Criteria:

-

  1. The termination of pregnancy is related to the health of the fetus

-

2. The fetus is not intact in development.

-

3. The fetus has malformations, abnormalities

-

       4. Estimation of gestational age based on parietal-rump length must not be within
          8-13 weeks of gestation.

Study details
    Cryptorchidism

NCT06560086

Affiliated Hospital of Nantong University

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.